GRID2 expressing cells had a microglia-like morphology, and were abundantly present in AD samples with tau pathology but rarely identified in CTR and AD samples without tau pathology (Fig. 4e, Fig S8a and b). This evidence concerns the gene GRID2 and Alzheimer disease.